{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:53:41Z","timestamp":1786978421831,"version":"build-2736575974"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Characterization of circulating tumor DNA (ctDNA) has been integrated into clinical practice. Although labs have standardized validation procedures to develop single locus tests, the efficacy of on-site plasma-based next-generation sequencing (NGS) assays still needs to be proved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>In this retrospective study, we profiled DNA from matched tissue and plasma samples from 75 patients with cancer. We applied an NGS test that detects clinically relevant alterations in 33 genes and microsatellite instability (MSI) to analyze plasma cell-free DNA (cfDNA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The concordance between alterations detected in both tissue and plasma samples was higher in patients with metastatic disease. The NGS test detected 77% of sequence alterations, amplifications, and fusions that were found in metastatic samples compared with 45% of those alterations found in the primary tumor samples (p\u00a0=\u00a0.00005). There was 87% agreement on MSI status between the NGS test and tumor tissue results. In three patients, MSI-high ctDNA correlated with response to immunotherapy. In addition, the NGS test revealed an FGFR2 amplification that was not detected in tumor tissue from a patient with metastatic gastric cancer, emphasizing the importance of profiling plasma samples in patients with advanced cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our validation experience of a plasma-based NGS assay advances current knowledge about translating cfDNA testing into clinical practice and supports the application of plasma assays in the management of oncology patients with metastatic disease. With an in-house method that minimizes the need for invasive procedures, on-site cfDNA testing supplements tissue biopsy to guide precision therapy and is entitled to become a routine practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications for Practice<\/jats:title>\n                    <jats:p>This study proposes a solution for decentralized liquid biopsy testing based on validation of a next-generation sequencing (NGS) test that detects four classes of genomic alterations in blood: sequence mutations (single nucleotide substitutions or insertions and deletions), fusions, amplifications, and microsatellite instability (MSI). Although there are reference labs that perform single-site comprehensive liquid biopsy testing, the targeted assay this study validated can be established locally in any lab with capacity to offer clinical molecular pathology assays. To the authors' knowledge, this is the first report that validates evaluating an on-site plasma-based NGS test that detects the MSI status along with common sequence alterations encountered in solid tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/onco.13905","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T10:23:28Z","timestamp":1626690208000},"page":"e1971-e1981","source":"Crossref","is-referenced-by-count":20,"title":["Validation of a Circulating Tumor\n                    <scp>DNA<\/scp>\n                    -Based\n                    <scp>Next-Generation<\/scp>\n                    Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0684-1180","authenticated-orcid":false,"given":"Wael","family":"Al Zoughbi","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Fox","sequence":"additional","affiliation":[{"name":"Personal Genome Diagnostics Inc., Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaham","family":"Beg","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eniko","family":"Papp","sequence":"additional","affiliation":[{"name":"Personal Genome Diagnostics Inc., Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Hissong","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Ohara","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel","family":"Keefer","sequence":"additional","affiliation":[{"name":"Personal Genome Diagnostics Inc., Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sigouros","sequence":"additional","affiliation":[{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Kane","sequence":"additional","affiliation":[{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bockelman","sequence":"additional","affiliation":[{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Nichol","sequence":"additional","affiliation":[{"name":"Personal Genome Diagnostics Inc., Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Patchell","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Bareja","sequence":"additional","affiliation":[{"name":"Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aanavi","family":"Karandikar","sequence":"additional","affiliation":[{"name":"Personal Genome Diagnostics Inc., Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Alnajar","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Cerqueira","sequence":"additional","affiliation":[{"name":"Personal Genome Diagnostics Inc., Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta Beleva","family":"Guthrie","sequence":"additional","affiliation":[{"name":"Personal Genome Diagnostics Inc., Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Verner","sequence":"additional","affiliation":[{"name":"Personal Genome Diagnostics Inc., Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyothi","family":"Manohar","sequence":"additional","affiliation":[{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Greco","sequence":"additional","affiliation":[{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wilkes","sequence":"additional","affiliation":[{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Tagawa","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtaza S.","family":"Malbari","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Weill Cornell Medicine, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Holcomb","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth Wha","family":"Eng","sequence":"additional","affiliation":[{"name":"Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser K.","family":"Altorki","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sboner","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA"},{"name":"Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nanus","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishoy","family":"Faltas","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York, USA"},{"name":"Department of Cell and Developmental Biology, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora N.","family":"Sternberg","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Simmons","sequence":"additional","affiliation":[{"name":"Personal Genome Diagnostics Inc., Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yariv","family":"Houvras","sequence":"additional","affiliation":[{"name":"Department of Surgery, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Molina","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Angiuoli","sequence":"additional","affiliation":[{"name":"Personal Genome Diagnostics Inc., Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Elemento","sequence":"additional","affiliation":[{"name":"Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Miguel","family":"Mosquera","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA"},{"name":"The Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"key":"2022011714461622500_onco13905-bib-0001","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/annonc\/mdz031","article-title":"Recent advances in circulating nucleic acids in oncology","volume":"30","author":"Otandault","year":"2019","journal-title":"Ann Oncol"},{"key":"2022011714461622500_onco13905-bib-0002","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2217\/fon.11.122","article-title":"Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer","volume":"7","author":"De Mattos-Arruda","year":"2011","journal-title":"Future Oncol"},{"key":"2022011714461622500_onco13905-bib-0003","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/annonc\/mdy512","article-title":"Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping","volume":"30","author":"Zugazagoitia","year":"2019","journal-title":"Ann Oncol"},{"key":"2022011714461622500_onco13905-bib-0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3343\/alm.2018.38.1.1","article-title":"Cell-free DNA in oncology: Gearing up for clinic","volume":"38","author":"Ulrich","year":"2018","journal-title":"Ann Lab Med"},{"key":"2022011714461622500_onco13905-bib-0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.21037\/atm.2017.01.32","article-title":"The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer?","volume":"5","author":"Kwapisz","year":"2017","journal-title":"Ann Transl Med"},{"key":"2022011714461622500_onco13905-bib-0006","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1158\/1078-0432.CCR-15-2470","article-title":"Circulating cell-free tumor DNA analysis of 50 genes by next-generation sequencing in the prospective MOSCATO trial","volume":"22","author":"Jovelet","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2022011714461622500_onco13905-bib-0007","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1093\/annonc\/mdx405","article-title":"Next-generation sequencing (NGS) of cell-free circulating tumor DNA and tumor tissue in patients with advanced urothelial cancer: A pilot assessment of concordance","volume":"28","author":"Barata","year":"2017","journal-title":"Ann Oncol"},{"key":"2022011714461622500_onco13905-bib-0008","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40246-019-0220-8","article-title":"Next-generation sequencing in liquid biopsy: Cancer screening and early detection","volume":"13","author":"Chen","year":"2019","journal-title":"Hum Genomics"},{"key":"2022011714461622500_onco13905-bib-0009","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1158\/1535-7163.MCT-17-1038","article-title":"Next-Generation sequencing of tissue and circulating tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy experience with breast malignancies","volume":"18","author":"Shatsky","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"2022011714461622500_onco13905-bib-0010","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2147\/OTT.S81995","article-title":"Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making","volume":"8","author":"Weiss","year":"2015","journal-title":"Onco Targets Ther"},{"key":"2022011714461622500_onco13905-bib-0011","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1158\/1078-0432.CCR-19-1372","article-title":"Noninvasive detection of microsatellite instability and high tumor mutation burden in cancer patients treated with PD-1 blockade","volume":"25","author":"Georgiadis","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2022011714461622500_onco13905-bib-0012","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1158\/1078-0432.CCR-19-1324","article-title":"Validation of microsatellite instability detection using a comprehensive plasma-based genotyping panel","volume":"25","author":"Willis","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2022011714461622500_onco13905-bib-0013","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/annonc\/mdz196","article-title":"Liquid biopsy in the era of immuno-oncology: Is it ready for prime-time use for cancer patients?","volume":"30","author":"Hofman","year":"2019","journal-title":"Ann Oncol"},{"key":"2022011714461622500_onco13905-bib-0014","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan2415","article-title":"Direct detection of early-stage cancers using circulating tumor DNA","volume":"9","author":"Phallen","year":"2017","journal-title":"Sci Transl Med"},{"key":"2022011714461622500_onco13905-bib-0015","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000702","article-title":"Development of personalized tumor biomarkers using massively parallel sequencing","volume":"2","author":"Leary","year":"2010","journal-title":"Sci Transl Med"},{"key":"2022011714461622500_onco13905-bib-0016","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar7939","article-title":"A machine learning approach for somatic mutation discovery","volume":"10","author":"Wood","year":"2018","journal-title":"Sci Transl Med"},{"key":"2022011714461622500_onco13905-bib-0017","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jmoldx.2017.01.011","article-title":"Guidelines for validation of next-generation sequencing-based oncology panels: A joint consensus recommendation of the Association for Molecular Pathology and College of American Pathologists","volume":"19","author":"Jennings","year":"2017","journal-title":"J Mol Diagn"},{"key":"2022011714461622500_onco13905-bib-0018","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jmoldx.2018.05.004","article-title":"Analytical validation of a hybrid capture-based next-generation sequencing clinical assay for genomic profiling of cell-free circulating tumor DNA","volume":"20","author":"Clark","year":"2018","journal-title":"J Mol Diagn"},{"key":"2022011714461622500_onco13905-bib-0019","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/jdv.16766","article-title":"The predictive and prognostic significance of cell-free DNA concentration in melanoma","volume":"35","author":"V\u00e1raljai","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022011714461622500_onco13905-bib-0020","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/annonc\/mdz139","article-title":"Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy","volume":"30","author":"Hamfjord","year":"2019","journal-title":"Ann Oncol"},{"key":"2022011714461622500_onco13905-bib-0021","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.tranon.2018.07.013","article-title":"Measuring KRAS mutations in circulating tumor DNA by droplet digital PCR and next-generation sequencing","volume":"11","author":"Demuth","year":"2018","journal-title":"Transl Oncol"},{"key":"2022011714461622500_onco13905-bib-0022","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cllc.2017.10.017","article-title":"Utility of liquid biopsy by improved PNA-LNA PCR clamp method for detecting EGFR mutation at initial diagnosis of non-small-cell lung cancer: Observational study of 190 consecutive cases in clinical practice","volume":"19","author":"Ito","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"2022011714461622500_onco13905-bib-0023","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s12094-018-1855-y","article-title":"Comparison of plasma ctDNA and tissue\/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS","volume":"20","author":"Arriola","year":"2018","journal-title":"Clin Transl Oncol"},{"key":"2022011714461622500_onco13905-bib-0024","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/annonc\/mdy061","article-title":"RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: The AGEO RASANC prospective multicenter study","volume":"29","author":"Bachet","year":"2018","journal-title":"Ann Oncol"},{"key":"2022011714461622500_onco13905-bib-0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/1878-0261.12646","article-title":"The potential of combined mutation sequencing of plasma circulating cell-free DNA and matched white blood cells for treatment response prediction","volume":"14","author":"Leest","year":"2020","journal-title":"Mol Oncol"},{"key":"2022011714461622500_onco13905-bib-0026","doi-asserted-by":"crossref","DOI":"10.1200\/PO.18.00191","article-title":"Orthogonal comparison of four plasma NGS tests with tumor suggests technical factors are a major source of assay discordance","author":"Stetson","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"2022011714461622500_onco13905-bib-0027","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3390\/cancers11121938","article-title":"Assessing the concordance of genomic alterations between circulating-free DNA and tumour tissue in cancer patients","volume":"11","author":"Jahangiri","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2022011714461622500_onco13905-bib-0028","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/bioinformatics\/btt755","article-title":"MSIsensor: microsatellite instability detection using paired tumor-normal sequence data","volume":"30","author":"Niu","year":"2014","journal-title":"Bioinformatics"},{"key":"2022011714461622500_onco13905-bib-0029","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1038\/ncomms6383","article-title":"The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer","volume":"5","author":"Chakravarty","year":"2014","journal-title":"Nat Commun."},{"key":"2022011714461622500_onco13905-bib-0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40478-020-00951-4","article-title":"Fusions involving BCOR and CREBBP are rare events in infiltrating glioma","volume":"8","author":"Pisapia","year":"2020","journal-title":"Acta Neuropathol Commun."},{"key":"2022011714461622500_onco13905-bib-0031","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/onco.13905","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/onco.13905","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/26\/11\/e1971\/42204093\/oncolo_26_11_e1971.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/26\/11\/e1971\/42204093\/oncolo_26_11_e1971.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T09:47:58Z","timestamp":1642412878000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/26\/11\/e1971\/6508804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,8,4]]},"published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1002\/onco.13905","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2021,8,4]]}}}